Purpose: To develop topical formulations of Clerodendrum petasites S. Moore (CP), and to optimise 12 the skin permeability and topical bioavailability of the active phenolic compounds therein. 13
Introduction 34
Clerodendrum petasites S. Moore (Lamiaceae, English name: One Root Plant, Thai name: Thao-Yaai-35
Mom) is commonly found in the middle, north-eastern and southern parts of Thailand. It is 36 extensively prepared as a tea, alcoholic extract, cigarette, or powder for oral administration to treat 37 asthma (Hazekamp et al., 2001; Panthong et al., 2003; Panthong et al., 1986) , inflammation 38 (Panthong et al., 1986) , fever, cough and vomiting (Panthong et al., 2003 ; Thai traditional medical 39 textbook: Paet-Ta-Ya-Saat-Song-Kror 2007) (S. Tungjitaruen, pers. comm., 2011). For topical use, the 40 traditional dosage form is a poultice to treat skin diseases, such as rash, abscess, urticaria, 41 snakebites and insect bites (Panthong et al., 2003; Pongboonrot, 1965 ; Thai traditional medical 42 textbook: Paet-Ta-Ya-Saat-Song-Kror 2007) (T. Tipcharoentham, pers. comm., 2011; S. Tungjitaruen, 43 pers. comm., 2011). Alcohol, especially Thai rice whisky, is often used as a dispersing vehicle in many 44 formulations before application. At present, only the plant itself and powders therefrom are found 45 on the market with poor reliability and reproducibility with respect to the active ingredients. These 46 forms are also inconvenient to use and transport. The nature of the active species remain poorly 47 characterized (Hazekamp et al., 2001; Klaiklay, 2009; Singharachai et al., 2011; Thongchai et al., 48 2007 ) and there is no information concerning the topical bioavailability of active species from this 49 plant. 50 A preliminary study, reported elsewhere (Thitilertdecha et al., 2014) , identified eleven phenolic 51 compounds, vanillic acid, 4-coumaric acid, ferulic acid, verbascoside, nepetin, luteolin, chrysin, 52 naringenin, hesperetin, apigenin, and hispidulin, in an ethanolic (80%) extract of the plant, predicted 53 their maximum skin fluxes (Jmax) and measured skin absorption in vitro from a 50% w/w CP paste and 54 a 50 mg•mL -1 CP solution. In the present study, suitable dosage forms for topical delivery to the skin 55 were developed and optimised, and the topical bioavailability of the active substances was 56 determined in vivo in human volunteers. 57 Fresh porcine abdominal skin was obtained from B&J Pigs Ltd, Somerset, UK. Excess hair was 85 carefully trimmed using scissors. After cleaning with running cold water, the skin was dermatomed 86 (Zimmer electric dermatome, Oklahoma, USA) to a nominal thickness of 750 µm. The dermatomed 87 skin was sealed in a plastic bag and stored at -20 ○ C until use. 88
Materials and methods

Human subjects 89
Six healthy volunteers aged between 25 and 31 years (4 females and 2 males), with no history of skin 90 disease, no visible skin abnormalities and no prior skin treatment in the preceding 4 weeks, 91 participated in the study. Written informed consent was obtained from each subject before the 92 study, which was approved by the University of Bath Ethics Committee. 93
Cream and lotion formulations 94
Excipients of the cream and lotion are in Table I . They were formulated and then stored in a light-95 protective and airtight container at 4 ○ C. 96 
98
** A preservative mixture of methyl paraben (10 g) and propyl paraben (2 g) in propylene glycol (100 mL). 99 6 Analytical methods 100 6.1 High performance liquid chromatography coupled with mass spectrometry (HPLC-MS) 101 HPLC-MS was performed on a Shimadzu HPLC-2010A HT system (Shimadzu Corp., Kyoto, Japan) 102 consisting of an autosampler, vacuum degasser, and UV detector operating at 260 and 330 nm. 103
The HPLC was interfaced to a Shimadzu MS-2010EV system (Shimadzu Corp., Kyoto, Japan) with a 104 dual source of electrospray ionization and atmospheric pressure chemical ionization (ESI/APCI, DUIS-105 2010, Japan). Ionization was achieved in both negative-and positive-ion-modes with the detector 106 voltage set at 1.5 kV. Nitrogen was used as a nebulising gas, heated to 480 ○ C and delivered at a flow 107 rate of 1.5 L·min -1 . MS signals collected in the single ion-monitoring (SIM) mode were used for 108 quantification of individual compounds. 109
The column used was a Dionex Acclaim® 120 (C18, 5 µm, 150 x 4.6 mm i.d.). The mobile phase was a 110 combination of acetonitrile (A) and 0.1% aqueous acetic acid (v/v, B) with an optimized gradient 111 system of 20% A for 9 min, 20-60% A for 6 min, 60% A for 5 min, 60-95% A for 10 min, 95% A for 5 112 min and 20% A for 25 min. The injection volume was 20 µL and the flow rate was 0.5 mL·min -1 . The 113 column temperature was maintained at 35 ○ C throughout the analysis. All data acquired were 114 processed by the LabSolutions LCMS Software (Shimadzu Corp., Kyoto, Japan). 115 6.2 HPLC coupled to ultraviolet and photodiode array detection (HPLC-UV-PDA) 116 HPLC-UV-PDA was carried out using an ASI-100 automated sample injector, thermostatted column 117 compartment TCC-100 and PDA-100 photodiode array detector (Dionex® Ltd., UK). The UV detection 118 wavelengths were 260 and 330 nm for quantification and the maximum wavelengths (λmax) of each 119 peak were confirmed by a wavelength scan from 240 to 360 nm. 120 A HiQ Sil C18 HS column (C18, 5 µm, 150 x 4.6 mm i.d., Kyatech, Japan) was used at a temperature of 121 mobile phase in a gradient system of 0% A for 9 min, 0-50% A for 6 min, 50% A for 5 min, 50-94% A 124 for 10 min, 94% A for 5 min and 0% A for 25 min with a flow rate of 0.5 mL·min -1 . 20 µL of each 125 sample was injected. Chromatograms were interpreted with Chromeleon software (Dionex® Ltd., 126 UK). Retention times (tR) and UV peak detection using HPLC-PDA were compared with those using 127
HPLC-MS. 128 7 In vitro skin penetration experiments 129
The skin permeation of compounds in the plant extracts was determined in vertical, glass Franz 130 diffusion cells (PermeGear, Inc., Bethlehem, PA, USA). The exposed membrane surface area was 1.77 131 cm 2 and the receptor solution was 7.5 mL of a mixture of ethanol and 5 mM Tris buffer in ratio of 1:4 132 v/v, at pH 7.3 (i.e., slightly less than 7.4 due to the presence of ethanol). Frozen dermatomed pig 133 abdominal skin was thawed for 30 minutes before use and examined visually for punctures or 134 defects. The skin was stripped with one adhesive tape (3.5 cm x 3.5 cm, Scotch book tape, 3M, MN, 135 USA) to remove SC disjunctum before being mounted into the Franz cell. After temperature 136 equilibration at 37 ○ C, approximately 0.2 g of the formulations was applied to the skin surface and 137 occluded with Parafilm™ (Bemis Company, Inc., Neenah, WI). After 6 hours, the whole receptor 138 solution volume was removed and stored at 4 ○ C under light protection before quantitative analysis. 139
The skin was subsequently taken out of the Franz cell and the remaining formulation was removed 140 with an isopropyl alcohol swab (70% isopropyl alcohol; Sterets ® , Medlock Medical Ltd., UK). The skin 141 was then pinned to a polystyrene board and left to air dry for 3 hours. A template with a circular 142 aperture (1.4 cm diameter, Scotch book tape, 3M, MN, USA) was positioned over the treated area 143 before stripping the SC using tapes. Six replicates were performed with each formulation. 144 8 In vivo skin penetration experiments 145
The passive diffusion of constituents of the two plant extract formulations into the SC of healthy 146 volunteers was studied over 2 days. On day 1, the first formulation was applied to one arm; on day 147 2, the second formulation was applied to the other. The ventral forearms were cleaned with an 148 alcohol wipe and the subject was acclimatized to the treatment venue for 30 minutes. Four skin sites 149
(3 treated + 1 blank, control) were delineated on each arm at least 4 cm above the wrist and a 150 minimum of 4 cm below the elbow. Each treatment site (6 cm 2 in area, Figure 1 ) was demarcated 151 with a rectangular frame cut from a self-adhesive foam (1.57 mm in thickness; 3M, USA) and applied 152 to the ventral forearm with the long dimension oriented across the forearm. One tape strip was 153 discarded before drug application to remove SC disjunctum. Good contact between tape and skin 154 was ensured by running a weighted roller (6 cm wide, 140 g cm -2 ) over the tape several times before 155 The mass of skin removed on each tape was determined by weighing the tapes on a microbalance 181 (Satorius model SE2-F, Sartorius AG, Germany), before and after application to the skin. Before 182 weighing, the tapes were stored at room temperature for at least 12 hours and static electricity was 183 discharged (R50 discharging bar and ES50 power supply, Eltex Elektrostatik GmbH, Weil am Rhein, 184 Germany). 185
After weighing, the tapes were grouped for methanol extraction. The first and second tapes were 186 individually analysed, while the remaining tape strips were combined into groups of 2-4 tapes 187 depending on the total number collected in each experiment. Groups containing 1-2 tapes were 188 extracted with 1 mL of methanol, those with 3-4 tapes were extracted into 1.5 mL. Extraction 
213
All compounds except verbascoside were delivered from both cream and lotion vehicles and were 214 detected in the receptor phase after 6 hours (Table II) . Results from tape-stripping (Table II) were 215 consistent with these findings. Vanillic acid and hispidulin were taken up into the SC and crossed the 216 skin well. Verbascoside was only found in the SC and was not percutaneously absorbed. Little 217 difference was observed between the two formulations. 218 2 In vivo SC uptake of CP constituents from a cream and a lotion 219
Cumulative amounts of vanillic acid, nepetin and hispidulin taken up into the SC of the individual 220 volunteers from the cream and lotion are presented in Table III . Transport of hispidulin from the 221 cream (1 nmol·cm -2 ) was approximately double that of nepetin and vanillic acid (0.4, and 0.3 nmol·cm -2 , respectively). The penetration of these three compounds from the lotion was similar to 223 those from the cream. Verbascoside was not detectable in the SC following application of either the 224 cream or the lotion. Reproducibility was good and the robustness of the in vivo methodology was 225 demonstrated by low inter-subject variability: CVs were less than 29% for hispidulin, 44% for vanillic 226 acid, and 55% for nepetin from both formulations. 227 
231
When nepetin was detected by MS in volunteer 6, the level observed was small. While there should 232 be little or no difference between the PDA and MS assays, it is possible that the PDA peak for 233 nepetin was subject to interference by other compounds in the plant extract with a similar retention 234 time (e.g., luteolin). It is possible, therefore, that the nepetin quantities found in volunteers 1-5 235 using PDA may over-estimate the actual amounts present in the SC. In contrast, no interfering peaks 236 with those of vanillic acid and hispidulin were apparent. 237 inflammatory (Clavin et al., 2007; Gil et al., 1994; Kim et al., 2011) , and antioxidant activities (Kang et 255 al., 2009) . Verbascoside was included in the present study because of its apparent affinity to the SC 256 and because its structure and physicochemical properties predict that it is a poor permeant (i.e., it 257 serves as a "negative" control for the other three compounds). 258
An o/w cream and an o/w lotion containing excipients expected to enhance skin penetration (e.g., 259
propylene glycol, glycerol, and the surfactants Tween 60 and Span 60) were formulated to improve 260 permeability of the four selected actives. The concentration of CP was controlled at 10% by weight 261 which has been reported as the maximal concentration of plant ethanolic extracts in topical 262 products without measurable toxicity (Diwan et al., 2001) . A secondary objective was to avoid the 263 use of ethanol as this co-solvent may alter the barrier function and irritate the skin. Hispidulin 264 penetrated in the greatest amount followed by vanillic acid and nepetin. Verbascoside was only 265 taken up into the SC and was not percutaneously absorbed. No significant difference was observed 266 between the two formulations, the excipients of which were similar. 267
The theoretically predicted uptake (determined from the calculated Jmax values determined in the 268 preliminary study (Thitilertdecha et al., 2014) ) can be qualitatively compared with the experimental 269 data in Table II . Verbascoside's poor permeability was as anticipated (predicted uptake of only 0.003 270 nmol·cm -2 ). Vanillic acid was indeed well-absorbed but its penetration was much lower than that 271 expected from the predicted Jmax (440 nmol·cm -2 ). This is most likely because the formulations 272 contained vanillic acid at much less than its saturation concentration. The same conclusion fits with 273 the results for nepetin and hispidulin, the experimental absorption of which was lower than that 274 predicted from their calculated Jmax values (1.2 and 2.4 nmol·cm -2 , respectively). 275
Although delivery of the compounds from the CP cream and lotion were less than those predicted 276 from saturated solution, the percentage penetration observed (Table II) was greater than that from 277 the hydroalcoholic solution used in the preliminary study (Thitilertdecha et al., 2014) . This may be 278 due to the presence of surfactants in the cream and lotion formulations facilitating the solubilisation 279 of the compounds in the SC. 280
The in vivo and in vitro SC uptake data are compared in Figure 3 and show good overall agreement. 281 SC uptake in vitro was generally higher than in vivo and statistically significant differences were 282 found for nepetin and hispidulin (P < 0.01 and < 0.001, respectively). Verbascoside taken up into the 283 SC never reached the analytical LOQ in vivo. Thus, while quantitative extrapolation from in vitro 284 results to the in vivo situation may not be possible, it appears that in vitro experiments would be 285 useful for formulation development. This is the first investigation of the topical delivery of products containing extracts of C. petasites in 301 vitro and in vivo in humans. Four naturally-occurring active compounds in the plant, vanillic acid, 302 verbascoside, nepetin and hispidulin, were identified as relevant actives for skin permeation studies. 303
The four compounds, based on their uptake and penetration into the skin, together with their 304 known biological activities, may be considered as feasible candidates for the development of novel 305 and effective antimicrobial, anti-inflammatory, and antioxidant formulations and support the 306 ethnomedical uses of C. petasites in Thailand. It was also found that the in vitro model and the tape-307 stripping method were robust and effective to establish guidelines for topical delivery studies of 308 natural products. Both lotion and cream formulations containing C. petasites extracts are potential 309 standardised medicines for the Thai market, but show some stability problems, that require further 310 development. Overall, this study demonstrates a feasible approach to developing a series of topical 311 medicines that retain the herbal ingredients that many patients value whilst achieving higher levels 312 of standardisation and quality than currently exist on the market. 
